Skip to content

Medical-device intelligence

Abbott Molecular, Inc.: FDA clearances and recalls

Research Abbott Molecular, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Also included in Abbott’s selected company group. This exact FDA-name profile remains available separately.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

16 clearance records and 30 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Jul 10, 2008 to Sep 25, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

46 matching records
Device / recordCompany in FDA recordSourceSource date
Alinity m HCVK252102 · MZPAbbott Molecular, Inc.510(k)Sep 25, 2025FDA decision date
Alinity m EBV (09N43-095)K243489 · QLXAbbott Molecular, Inc.510(k)Jul 28, 2025FDA decision date
Alinity m CMVK243485 · PABAbbott Molecular, Inc.510(k)Jul 1, 2025FDA decision date
Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reac…Z-1748-2025 · QJRAbbott Molecular, Inc.RecallMay 12, 2025FDA classification date
Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test inten…Z-1749-2025 · QJRAbbott Molecular, Inc.RecallMay 12, 2025FDA classification date
The Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers included in this recall are 08N53-001, 08N53-002, …Z-1665-2025 · OOIAbbott Molecular, Inc.RecallApr 24, 2025FDA classification date
Alinity m BKVK241921 · QMIAbbott Molecular, Inc.510(k)Mar 24, 2025FDA decision date
Alinity m Resp-4-PlexK241573 · QOFAbbott Molecular, Inc.510(k)Feb 14, 2025FDA decision date
Abbott Alinity m HPV AMP Kit, used with the Alinity m System, product codes: a) REF 09N15-095; b) REF 09N15-090; c) REF 09N15-091Z-0233-2025 · MAQAbbott Molecular, Inc.RecallOct 29, 2024FDA classification date
Abbott Alinity m STI AMP Kit, used with the Alinity m System, product codes: a) REF 09N17-095; b) REF 09N17-090; c) REF 09N17-091;Z-0234-2025 · QEPAbbott Molecular, Inc.RecallOct 29, 2024FDA classification date
Alinity m HSV 1 & 2 / VZVK233349 · PGIAbbott Molecular, Inc.510(k)May 3, 2024FDA decision date
Alinity m System, Part Number: 08N53-002Z-1602-2024 · OOIAbbott Molecular, Inc.RecallApr 19, 2024FDA classification date
In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Pr…Z-1188-2024 · OYUAbbott Molecular, Inc.RecallFeb 26, 2024FDA classification date
In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020; (2) Abbott Vysis PTEN/CEP 10 FISH Probe Kit, RE…Z-1189-2024 · MVUAbbott Molecular, Inc.RecallFeb 26, 2024FDA classification date
Wash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare to the M2000sp.)Z-1190-2024 · OOIAbbott Molecular, Inc.RecallFeb 26, 2024FDA classification date
Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymeras…Z-0407-2024 · MZPAbbott Molecular, Inc.RecallNov 29, 2023FDA classification date
Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.Z-1349-2023 · OOIAbbott Molecular, Inc.RecallApr 6, 2023FDA classification date
Alinity m STI AssayK222379 · QEPAbbott Molecular, Inc.510(k)Mar 3, 2023FDA decision date
Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplifica…Z-1009-2023 · OOIAbbott Molecular, Inc.RecallJan 20, 2023FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096Z-0739-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090Z-0740-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
Alinity m System, REF 08N53-002, For In Vitro Diagnostic UseZ-0268-2023 · OOIAbbott Molecular, Inc.RecallNov 18, 2022FDA classification date
Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use.Z-1679-2022 · QJRAbbott Molecular, Inc.RecallSep 6, 2022FDA record creation date
The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Z-1518-2022 · MZPAbbott Molecular, Inc.RecallAug 12, 2022FDA record creation date
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)K212778 · QLXAbbott Molecular, Inc.510(k)Jul 15, 2022FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗